Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 22 Apr | 86.45 |
14.40 (19.99%) |
OPEN
74.90 |
HIGH
86.45 |
LOW
74.90 |
| NSE 00:00 | 22 Apr | 86.25 |
14.35 (19.96%) |
OPEN
75.40 |
HIGH
86.25 |
LOW
75.00 |
| OPEN | 74.90 |
| PREVIOUS CLOSE | 72.05 |
| VOLUME | 123554 |
| 52-Week high | 86.45 |
| 52-Week low | 33.50 |
| P/E | 221.67 |
| Mkt Cap.(Rs cr) | 128 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Half Yearly Result
Particulars ( cr) |
Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 |
| Net Sales/Income From Operations | 116.33 | 76.77 | 93.91 | 111.96 | 111.12 |
| Other Income | 0.88 | 2.61 | 1.01 | 1.95 | 0.79 |
| Total Income | 117.21 | 79.38 | 94.91 | 113.91 | 111.92 |
| Total Expenditure | 103.20 | 73.75 | 90.17 | 101.62 | 101.15 |
| Operating Profit | 14.01 | 5.63 | 4.74 | 12.29 | 10.77 |
| Interest | 5.95 | 5.81 | 6.61 | 6.76 | 5.77 |
| Gross Profit | 8.06 | -0.18 | -1.87 | 5.53 | 5.00 |
| Depreciation | 3.30 | 4.38 | 2.65 | 3.53 | 2.58 |
| PBT | 4.77 | -4.56 | -4.52 | 1.99 | 2.42 |
| Tax | 1.60 | 0.97 | -1.14 | -1.97 | -0.38 |
| Net Profit/(Loss) | 3.17 | -5.53 | -3.38 | 3.96 | 2.80 |
| Minority Interest After NP | - | - | - | - | - |
| Net Profit after Minority Interest | - | - | - | - | - |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit After Exceptional Items | 3.17 | -5.53 | -3.38 | 3.96 | 2.80 |
| Equity Share Capital | 14.17 | 14.17 | 14.17 | 14.17 | 14.17 |
| Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS | |||||
| Basic EPS | 2.24 | 0.00 | -2.38 | 2.80 | 1.97 |
| Public Share Holding | |||||
| No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Promoters and Promoter Group Shareholding | |||||
| a) Pledged/Encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| b) Non-encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. | ||||
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
